Responsible data monetisation can provide insights into disease patterns and patient demographics

Healthcare organisations collect and store a wealth of information, including patient records, medical images and treatment outcomes. Monetising this data involves analysing, packaging and selling insights derived from it. Enlitic can help enable an organisation’s data monetisation strategy.

One avenue is through collaborations with pharmaceutical companies, research institutions or technology firms. By anonymising and aggregating patient data, healthcare organisations can provide insights into disease patterns, treatment effectiveness and patient demographics. Pharmaceutical companies may purchase data to enhance their research and development efforts, streamline clinical trials and target specific patient populations.

Healthcare providers can also monetise data by offering analytical services to other organisations seeking to improve healthcare delivery.

Enlitic says that the first step in developing a strategy is to ensure the quality of data is sufficient for the purposes. One way to ensure high quality data is to standardise and curate it so that it is complete, accurate and uniform. “Strict regulations and safeguards must be adhered to,” the company points out. “Balancing the potential economic benefits with the need to protect patient privacy is crucial for the responsible and sustainable implementation of data monetisation.”

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated ECR conference page to find out more.